| Esther M Motlhatlhedi, MD | |
|
750 Town Park Lane, Paiser Permanente Town Park Medical Office-dept Of Ambu, Kennesaw, GA 30144 | |
| (908) 337-3212 | |
| Not Available |
| Full Name | Esther M Motlhatlhedi |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 750 Town Park Lane, Kennesaw, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023347010 | NPI | - | NPPES |
| 100216583 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 25MA08695200 (New Jersey) | Secondary |
| 207Q00000X | Family Medicine | 63883 (Georgia) | Primary |
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Depression doesn't come from one gene, one life event, or one personality trait. That's what makes it so hard to predict, prevent or treat effectively.
Children who have a mother diagnosed with a mental illness are at risk of psychiatric and behavioral problems, yet these children often fail to receive needed services, a new University of Michigan study indicates.
At least 30 new diseases have emerged in the last 20 years and now together threaten the health of hundreds of millions of people. For many of these diseases, there is no treatment, cure, or vaccine. While most of these diseases are dangerous to children, especially those younger than five years old, the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), seems to spare most of them.
Large quantities of antibiotic-resistant bacteria enter the environment via municipal - and especially hospital - wastewater streams. Although wastewater treatment plants reduce the total number of bacteria, the most hazardous - multiresistant - strains appear to withstand or even to be promoted by treatment processes. This was demonstrated by Eawag researchers in a study carried out in Lake Geneva, near Lausanne.
Oncolytics Biotech Inc. has announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a clinical trial using intravenous administration of REOLYSIN in combination with cyclophosphamide, a chemotherapeutic agent as well as immune modulator, in patients with advanced cancers.
› Verified 8 days ago
| Entity Name | Lakeshore Medical Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003861188 PECOS PAC ID: 7719890730 Enrollment ID: O20031106000481 |
News Archive
Depression doesn't come from one gene, one life event, or one personality trait. That's what makes it so hard to predict, prevent or treat effectively.
Children who have a mother diagnosed with a mental illness are at risk of psychiatric and behavioral problems, yet these children often fail to receive needed services, a new University of Michigan study indicates.
At least 30 new diseases have emerged in the last 20 years and now together threaten the health of hundreds of millions of people. For many of these diseases, there is no treatment, cure, or vaccine. While most of these diseases are dangerous to children, especially those younger than five years old, the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), seems to spare most of them.
Large quantities of antibiotic-resistant bacteria enter the environment via municipal - and especially hospital - wastewater streams. Although wastewater treatment plants reduce the total number of bacteria, the most hazardous - multiresistant - strains appear to withstand or even to be promoted by treatment processes. This was demonstrated by Eawag researchers in a study carried out in Lake Geneva, near Lausanne.
Oncolytics Biotech Inc. has announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a clinical trial using intravenous administration of REOLYSIN in combination with cyclophosphamide, a chemotherapeutic agent as well as immune modulator, in patients with advanced cancers.
› Verified 8 days ago
| Entity Name | Aurora Advanced Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265629133 PECOS PAC ID: 3375625833 Enrollment ID: O20080123000694 |
News Archive
Depression doesn't come from one gene, one life event, or one personality trait. That's what makes it so hard to predict, prevent or treat effectively.
Children who have a mother diagnosed with a mental illness are at risk of psychiatric and behavioral problems, yet these children often fail to receive needed services, a new University of Michigan study indicates.
At least 30 new diseases have emerged in the last 20 years and now together threaten the health of hundreds of millions of people. For many of these diseases, there is no treatment, cure, or vaccine. While most of these diseases are dangerous to children, especially those younger than five years old, the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), seems to spare most of them.
Large quantities of antibiotic-resistant bacteria enter the environment via municipal - and especially hospital - wastewater streams. Although wastewater treatment plants reduce the total number of bacteria, the most hazardous - multiresistant - strains appear to withstand or even to be promoted by treatment processes. This was demonstrated by Eawag researchers in a study carried out in Lake Geneva, near Lausanne.
Oncolytics Biotech Inc. has announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a clinical trial using intravenous administration of REOLYSIN in combination with cyclophosphamide, a chemotherapeutic agent as well as immune modulator, in patients with advanced cancers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Esther M Motlhatlhedi, MD 3495 Piedmont Road, Ne, Nine Piedmont Center, Atlanta, GA 30505-1736 Ph: (404) 365-0966 | Esther M Motlhatlhedi, MD 750 Town Park Lane, Paiser Permanente Town Park Medical Office-dept Of Ambu, Kennesaw, GA 30144 Ph: (908) 337-3212 |
News Archive
Depression doesn't come from one gene, one life event, or one personality trait. That's what makes it so hard to predict, prevent or treat effectively.
Children who have a mother diagnosed with a mental illness are at risk of psychiatric and behavioral problems, yet these children often fail to receive needed services, a new University of Michigan study indicates.
At least 30 new diseases have emerged in the last 20 years and now together threaten the health of hundreds of millions of people. For many of these diseases, there is no treatment, cure, or vaccine. While most of these diseases are dangerous to children, especially those younger than five years old, the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), seems to spare most of them.
Large quantities of antibiotic-resistant bacteria enter the environment via municipal - and especially hospital - wastewater streams. Although wastewater treatment plants reduce the total number of bacteria, the most hazardous - multiresistant - strains appear to withstand or even to be promoted by treatment processes. This was demonstrated by Eawag researchers in a study carried out in Lake Geneva, near Lausanne.
Oncolytics Biotech Inc. has announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a clinical trial using intravenous administration of REOLYSIN in combination with cyclophosphamide, a chemotherapeutic agent as well as immune modulator, in patients with advanced cancers.
› Verified 8 days ago
Dr. Maria A Schiaffino, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 Town Park Lane, Kennesaw, GA 30144 Phone: 770-514-5504 | |
Dr. Sharmila Ramprasad, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3104 Creekside Village Dr Nw, Suite 201, Kennesaw, GA 30144 Phone: 770-627-3986 Fax: 770-872-0517 | |
Dr. Nikia Lynette Garland, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 Townpark Ln Nw, Kaiser Permanente Townpark Medical Center, Kennesaw, GA 30144 Phone: 770-514-5401 | |
Dr. Mildred Joann Santorufo, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1275 Shiloh Rd Nw Ste 2051, Kennesaw, GA 30144 Phone: 678-737-4863 Fax: 706-222-4016 | |
Dr. William Godfrey, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3525 Busbee Dr Nw, Suite 100, Kennesaw, GA 30144 Phone: 770-422-0064 | |
Nihinlolawa Oreoluwa Ijamakinwa, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2481 George Busbee Pkwy Nw, Kennesaw, GA 30144 Phone: 770-423-0000 Fax: 770-423-0131 |